hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications
Authors:
- 1 October 2006
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 103 (1) , 321-328
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Histone deacetylase inhibitors – a new tool to treat cancerCancer Treatment Reviews, 2004
- Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repressionOncogene, 2003
- Suv39h-Mediated Histone H3 Lysine 9 Methylation Directs DNA Methylation to Major Satellite Repeats at Pericentric HeterochromatinCurrent Biology, 2003
- The Methyl-CpG-binding Protein MeCP2 Links DNA Methylation to Histone MethylationJournal of Biological Chemistry, 2003
- Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal CancerMolecular and Cellular Biology, 2003
- Transcriptional regulation of the mismatch repair gene hMLH1Gene, 2001
- Microsatellite instabilityCytogenetic and Genome Research, 2001
- hMLH1 Promoter Hypermethylation Is an Early Event in Human Endometrial TumorigenesisThe American Journal of Pathology, 1999
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- Liver-enriched Transcription Factor HNF-4 and Ubiquitous Factor NF-Y Are Critical for Expression of Blood Coagulation Factor XJournal of Biological Chemistry, 1996